(RTTNews) -  Osiris Therapeutics Inc. (OSIR: News ) reported a net loss of $6.2 million or $0.19 per share for the third quarter, compared to net gain of $5.3 million or $0.17 per share in the prior year quarter.

Third quarter revenues surged to $10.6 million from $1.0 million in the previous year quarter.
Analysts polled by Thomson Reuters expected the company to report a loss of $0.06 per share on revenue of $11.60 million for the quarter. Analysts' estimates typically exclude special items.

Click here to receive FREE breaking news email alerts for OSIRIS THERAPEUTICS and others in your portfolio

by RTT Staff Writer

For comments and feedback: contact editorial@rttnews.com